Varian expands HDR (high dose rate) brachytherapy with MDS deal
This article was originally published in Clinica
Executive Summary
Varian Medical Systems is to buy MDS Nordion's high dose rate (HDR) brachytherapy business for around $11m in cash. When combined with its own products, the deal will give Varian the broadest range of delivery systems and applicators for HDR brachytherapy, Palo Alto, California-based Varian says. It will also boost its presence in international markets, especially Europe.